1型糖尿病中体育活动的降糖效应:因果建模和匹配对分析方法
John S Pemberton1, Catherine L Russon2, Richard M Pulsford2
1Birmingham Women's and Children's Hospitals NHS Foundation Trust, Diabetes Centre, Birmingham, UK.
概括
身体活动有效降低高血糖在1型糖尿病. 这种安全的策略,以持续的葡萄糖监测为指导,为1型糖尿病患者提供了个性化的管理.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 运动生理学 运动生理学
背景情况:
- 高血糖是1型糖尿病患者的常见挑战.
- 有效的降血糖策略对于糖尿病管理至关重要.
- 众所周知,体力活动 (PA) 影响葡萄糖水平,但其在高血糖状态中的急性影响需要精确的评估.
研究的目的:
- 为了评估身体活动 (PA) 的急性降糖效果,在1型糖尿病患者中经历过高血糖症.
- 通过严格的在人体内设计,确定PA发作和葡萄糖降低之间的因果关系.
- 为了确定葡萄糖对PA反应的关键预测因子和与此相关的低血糖症风险.
主要方法:
- 采用了主体内匹配对的因果设计,分析了482名参与者的1546次PA发作 (10-30分钟),其葡萄糖>10 mmol/L.
- 根据使用k-最近邻近算法 (SMD <0.01) 根据同一个体的起始葡萄糖,葡萄糖变化率,在船上的胰岛素 (IOB) 和葡萄糖变化率 (CV) 精心匹配每个PA发作与非PA时期.
- 主要结局是从PA开始到活动后20分钟的葡萄糖变化.
主要成果:
- 在匹配的非PA期间,PA显著降低了平均-2.2 mmol/L的葡萄糖水平,而在匹配的非PA期间,血糖水平略有增加0.3 mmol/L (平均差异:-1.9 mmol/L,p < 0.0001).
- 最重要的PA诱导的葡萄糖降低预测因素是葡萄糖变化速度,开始葡萄糖,CV,持续时间和IOB.
- 开发了一个热图,以帮助实时决策,并发现PA诱导的低血糖症的风险非常低 (<2%).
结论:
- 身体活动是降低1型糖尿病高葡萄糖水平的有效和安全策略.
- 当与持续血糖监测 (CGM) 数据集成时,PA可以被个性化用于1型糖尿病教育和管理.
- 这种方法使得1型糖尿病患者能够通过运动积极管理高血糖症.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
583
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
583
Diabetes: Management and Pharmacotherapy
867
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
867
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Dipeptidyl Peptidase 4 Inhibitors
587
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
587


